Judgment of the General Court (Seventh Chamber) of 16 May 2019 (Extracts).#GMP-Orphan (GMPO) v European Commission.#Medicinal products for human use — Article 3(1)(b) of Regulation (EC) No 141/2000 — Definition of ‘significant benefit’ — Availability of orphan medicinal products — Article 5(12)(b) of Regulation No 141/2000 — Commission decision to remove a medicinal product from the Register of Orphan Medicinal Products — Error of assessment — Error of law — Legitimate expectations.#Case T-733/17.

Records

Official record CELEX 62017TJ0733 from European Union at Court of Justice of the European Union. Dated 16 May 2019. Status: decided.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Judgment of the General Court (Seventh Chamber) of 16 May 2019 (Extracts).#GMP-Orphan (GMPO) v European Commission.#Medicinal products for human use — Article 3(1)(b) of Regulation (EC) No 141/2000 — Definition of ‘significant benefit’ — Availability of orphan medicinal products — Article 5(12)(b) of Regulation No 141/2000 — Commission decision to remove a medicinal product from the Register of Orphan Medicinal Products — Error of assessment — Error of law — Legitimate expectations.#Case T-733/17.

  judgment · EN · 16 May 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.